Notes

The Catalyst fund, which is for research only and has a size of 0, was updated on September 24, 2026, at 21:15:19 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, LOVE on September 10, 2026, and SFIX on September 23, 2026. A SEC filing is a report that a company submits to the Securities and Exchange Commission. The manager also reviewed the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 24, 2026. An RSS feed is a way for companies to share news and updates. Additionally, the manager reviewed an FDA update on September 23, 2026, regarding a meeting of the Molecular and Clinical Genetics Panel, which is a group that advises the FDA on medical devices. The FDA, or Food and Drug Administration, is a government agency that regulates medical devices and drugs. The manager noted that SEC filings may not always be up to date with the latest news. The manager reviewed the following specific times: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC, which is the after-market close. The manager also noted that the GRAL panel on September 23 was not an approval. The manager made decisions based on strong cash, which means a company has a lot of money, and weak or early or absent cash, which means a company does not have much money. The manager did not make any automatic orders.

The fund is called Catalyst Research and its size is 0 as of 2026-09-24T18:30:27.002655+00:00. There are several news updates from various companies, including TLX on Sun, 20 Sep 2026, AVO on Tue, 08 Sep 2026, ABM on Thu, 24 Sep 2026, ROIV on Wed, 23 Sep 2026. Additionally, there are financial reports from UNFI on 2026-09-14, DRI on 2026-09-24, PPIH on 2026-09-09, MRK on 2026-08-07, and WLTH on 2026-09-14. There are also updates from EPM on Mon, 21 Sep 2026, and IPHA on 2026-09-17. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are 200, with corresponding hashes. The research is for informational purposes only, with instructions to read originals and validate strong or new information, and to cash and reverify weak or absent information. There are specific conditions and monitors in place, including IPHA on Sep 17 and Sobi receipt/Q1-2028 conditional. The sources and dates are recorded in the job script and journal, and there are no orders.

The Catalyst fund is currently researching IONS, MIRM, GIS, and EAT, with no active positions, as of September 24, 2026, at 17:45:36 UTC. The fund has reviewed SEC filings for IONS on September 23, MIRM on September 8, GIS on September 23, and EAT on September 17. A discovery on September 24 reported that HC Wainwright & Co reiterated a buy rating on Ionis Pharmaceuticals with a $100 price target. GIS had a conference on September 8, and the fund is waiting for the replay. On September 23, GIS released its earnings, and the fund is checking the Q&A session. The fund has a baseline expectation for GIS's fiscal year 2027, with an EPS of $3.00-3.20 and organic growth of -1.5% to +0.5%. The fund also reviewed EAT's investor day on September 17 and is waiting for its earnings call on October 28. The fund has set specific criteria for recording and verifying GIS and EAT's performance, with no automatic trades. The fund's research is ongoing, with a focus on verifying full pipelines and early news.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 24, 2026, at 17:00:36 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, ASO on September 9, LOVE on September 10, and SFIX on September 23. A SEC filing is a report that a company submits to the Securities and Exchange Commission, which is a government agency that regulates companies. The manager also reviewed the following RSS feeds: SAIL on September 22, KFY on September 9, and LOVE on September 24. An RSS feed is a way for companies to share news and updates with the public. Additionally, the manager reviewed a notice from the FDA, which is the Food and Drug Administration, a government agency that regulates food, drugs, and medical devices, regarding a meeting on September 23 about GRAL. The manager noted that the SEC filings may not be up to date with the latest news. The manager reviewed the following updates: new morning results on September 9 at 12:30 for LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30 after the market closed on September 23. The manager also noted that the GRAL panel on September 23 was not an approval. The manager made a decision to preserve 80 and exit 0, and noted that companies with strong cash flow should be validated, while those with weak or early cash flow should be verified again. The manager also stated that there would be no automatic orders.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-24T14:15:34.095635+00:00 UTC. There are several news updates: TLX on Sunday, September 20, 2026, from https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/, AVO on Tuesday, September 8, 2026, from https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Thursday, September 24, 2026, from https://abm.gcs-web.com/news-releases/news-release-details/abm-wins-2026-gartner-marketing-and-communications-award-brand, ROIV on Wednesday, September 23, 2026, from https://investor.roivant.com/news-releases/news-release-details/roivant-announces-topline-results-proof-concept-study-imvt-1402. There are also several financial reports: UNFI on September 14, 2026, 10-K report, DRI on September 24, 2026, 8-K report, PPIH on September 9, 2026, 10-Q report, MRK on August 7, 2026, 10-Q report, WLTH on September 14, 2026, 10-Q report, and IPHA on September 17, 2026, 6-K report. Additionally, there are website status updates: KGF, ASKUL, IPHAnews, and SOBI all have HTTP200 status with their respective hashes. The decision is to research only, with strong or new information requiring reading of originals and validation, and weak or absent information requiring cash and reverification. IPHA has a condition on September 17 and Sobi has a receipt and Q1-2028 condition. Monitors 165, 168, 167, 137, and 22 are preserved. There are no orders and sources and dates are in the job script and journal.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. As of September 24, 2026, at 13:30:44 UTC, the fund has the following information: IONS filed a SEC report on September 23, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/874015/000114036126037371/ef20082626_8k.htm. MIRM filed a SEC report on September 8, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/mirm-20260902.htm. GIS filed a SEC report on September 23, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/40704/000162828026063141/gis-20260923.htm. EAT filed a SEC report on September 17, 2026, which can be found at https://www.sec.gov/Archives/edgar/data/703351/000070335126000032/eat-20260917.htm. On September 24, 2026, at 10:59:30Z, HC Wainwright & Co. reiterated a Buy rating on Ionis Pharmaceuticals and maintained a $100 price target. GIS had a conference and review on September 8, 2026, at 19:40 UTC, which has already passed. The fund is waiting for the replay. On September 23, 2026, GIS released its earnings, and the fund is checking the Q&A session. The fund has a baseline expectation for GIS's fiscal year 2027, with an EPS of $3.00-3.20 and organic growth of -1.5% to +0.5%. The fund also has a frozen paper window from September 16 to September 21, with a calendar return of +0.567% and a stress return of -2.405%. EAT had an investor day on August 31, 2026, and the fund chose to review it on September 17, 2026, at 16:30 UTC. EAT also announced its earnings call date for October 28, 2026, and the fund will review it at 16:30 UTC. The fund is using a decision tree for EAT, where stronger organic cash flow will lead to recording and independent validation, while weaker or absent cash flow will lead to reverification. The fund has a frozen T5 holdout of -19.2065% and will not make any automatic trades. The fund is currently in research mode only and has not placed any orders. As of September 24, 2026, at 13:30:49 UTC, the fund is still in research mode.

A fund manager for the Catalyst research fund made some notes. The fund size is 0 and it is for research only. The notes are from the PRE91108 archive and were last updated on 2026-09-24 at 13:00:34. The manager looked at several companies, including HITI and BFRI, and checked their filings with the Securities and Exchange Commission. They also looked at news about Dave & Buster's and Egetis Therapeutics. The manager checked the US International Trade Commission website for information about BFRI. They also looked at some conference schedules and a federal register notice about BFRI. The manager has 11 panels of information to review, each with a unique code, or sha, to identify it.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 24, 2026, at 13:00:24 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, ASO on September 9, LOVE on September 10, and SFIX on September 23. A SEC filing, also known as a Securities and Exchange Commission filing, is a document that a company submits to the SEC to disclose certain information. The manager also reviewed the following RSS feeds: SAIL on September 22, KFY on September 9, and LOVE on September 24. An RSS feed, or Really Simple Syndication feed, is a way for websites to share updates. Additionally, the manager reviewed a FDA update, which is an update from the Food and Drug Administration, regarding GRAL on September 23. The manager noted that the SEC filings may not be up to date with the latest news. The manager reviewed the following updates at the specified times: new morning results on September 9 at 12:30, LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30 after the September 23 AMC, or after-market close. The manager also noted that the GRAL panel on September 23 was not an approval. The manager made decisions based on strong cash positions, which were recorded and validated, and weak or early cash positions, which were cashed and reverified. No automatic orders were made.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-24T10:15:30.155407+00:00. There are several news updates from various companies, including TLX on Sunday, September 20, 2026, which can be found at https://telixpharma.com/news-views/telix-and-itm-join-forces-to-create-a-radiopharmaceutical-powerhouse/, AVO on Tuesday, September 8, 2026, which can be found at https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-third-quarter-financial, ABM on Tuesday, September 22, 2026, which can be found at https://abm.gcs-web.com/news-releases/news-release-details/abm-launches-technical-training-center-help-meet-growing-demand, ROIV on Wednesday, September 23, 2026, which can be found at https://investor.roivant.com/news-releases/news-release-details/roivant-announces-topline-results-proof-concept-study-imvt-1402. There are also financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Additionally, there are updates from EPM on Monday, September 21, 2026, which can be found at https://ir.evolutionpetroleum.com/news-releases/news-release-details/evolution-petroleum-participate-upcoming-investor-conferences, and IPHA on September 17, 2026, which can be found at https://www.ipha.com, a 6-K report. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are 200, with hashes 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 9c07c8709019d6c1, respectively. The research is focused on strong and new information, and weak or absent information will be reverified. There is a condition for Sobi receipt and Q1-2028, and monitors 165, 168, 167, 137, and 22 will be preserved. There are no orders and the sources and dates can be found in the job script and journal.

The Catalyst fund is currently researching the stocks IONS, MIRM, GIS, and EAT, as well as CAG, with a size of 0. The fund manager has noted the following SEC filings: IONS on 2026-09-23, MIRM on 2026-09-08, GIS on 2026-09-23, and EAT on 2026-09-17. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on 2026-09-23. The GIS company had a conference on September 8, and the fund manager has noted to check the replay. On September 23, GIS released its morning earnings, and the fund manager has noted to review the Q&A session. The fund manager has set a baseline for GIS's fiscal year 2027, with an expected EPS of 3.00-3.20 and organic growth of -1.5 to +0.5%. The fund manager has also noted EAT's investor day on September 17 and its upcoming earnings call on October 28. The fund manager has set rules for trading GIS and EAT, including verifying full pipelines and early news. The fund is currently in research mode only, with no orders, as of 2026-09-24T09:30:43.703880+00:00.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 24, 2026, at 08:45:30 UTC. The fund reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, LOVE on September 10, 2026, and SFIX on September 23, 2026. The fund also reviewed the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. Additionally, the fund reviewed an FDA update for GRAL on September 23, 2026. The fund preserves 80 and exits 0. The fund will review new morning results on September 9 at 12:30 UTC, LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30 after the September 23 AMC. The GRAL panel on September 23 was not an approval. The fund has a strong cash position and will record and validate it, while weak or early positions will be cashed and reverified. No automatic orders were placed.

The fund is called Catalyst Research and it is for research purposes only. The size of the fund is 0 and the time of the update is September 24, 2026, at 06:00:42 UTC. There are several news updates from various companies, including Telix on September 20, 2026, Mission Produce on September 8, 2026, ABM on September 22, 2026, and Roivant on September 23, 2026. Additionally, there are financial reports from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Evolution Petroleum will participate in upcoming investor conferences on September 21, 2026, and IPHA filed a 6-K report on September 17, 2026. The HTTP requests for KGF, ASKUL, IPHAnews, and SOBI were successful with hashes 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08, respectively. The research notes end with the instruction to preserve monitors 165, 168, 167, 137, and 22, and to verify sources and dates in the job script and journal, with no orders to be placed.

The Catalyst fund is for research only, with a size of 0, as of September 24, 2026, at 05:30:36 UTC. The fund is tracking the following stocks: IONS, MIRM, GIS, EAT, and CAG. The Securities and Exchange Commission (SEC) filings for these stocks are available at the following links: IONS on September 23, MIRM on September 8, GIS on September 23, and EAT on September 17. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on September 23. General Mills, the company behind GIS, had a conference and review on September 8 at 19:40 UTC, which has already passed. The company also released its earnings on the morning of September 23, with a Q&A session at 13:00 UTC. The baseline expectations for GIS are an EPS of 3.00-3.20 for the fiscal year 2027, with organic growth between -1.5% and +0.5%, and savings of 750 million. Brinker International, the company behind EAT, had an investor day on August 31, and will have an earnings call on October 28. The fund's strategy is to record and validate stronger organic cash growth, and to reverify weaker or absent growth. No automatic trades will be made, and the fund will review the stocks on the following dates: September 23 for GIS, and October 28 for EAT. The fund's current status is for research only, with no orders, as of September 24, 2026, at 05:30:42 UTC.

A news scan found the headline of a job report. The job is for a catalyst research fund with a size of 0. It involves compacting receipts and has origins in the PRE91108 archive. The job was completed on 2026-09-24T04:45:39.617058+00:00. The job consists of 11 panels with various previews, including SEC filings for HITI and BFRI, and news about Dave & Buster's and Egetis Therapeutics. A piece of jargon, SEC, refers to the Securities and Exchange Commission. The job also mentions ITC, which refers to the International Trade Commission. The previews include links to the SEC website and other sources. The job report includes a list of panels with their corresponding SHA values and character counts. The report ends with a note to read the originals before taking action.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 24, 2026, at 04:45:26 UTC. The fund manager reviewed the following SEC filings: CHWY's 10-Q filing on September 9, 2026, ASO's 10-Q filing on September 9, 2026, LOVE's 10-Q filing on September 10, 2026, and SFIX's 8-K filing on September 23, 2026. The manager also reviewed the following RSS feeds: SAIL's announcement on September 22, 2026, KFY's press release on September 9, 2026, and LOVE's press release on September 15, 2026. Additionally, the manager noted GRAL's FDA panel meeting on September 23, 2026. The manager will review the SEC filings and RSS feeds at the following times: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The GRAL panel meeting on September 23 was not an approval. The manager will use a strong cash position to record and validate results, and a weak or early cash position to cash and reverify results. No automatic orders were placed.

The Catalyst research fund has a size of 0 as of September 24, 2026, at 02:00:35 UTC. Recent news includes: TLX on September 20, 2026, about a partnership with ITM, AVO on September 8, 2026, about fiscal third-quarter financial results, ABM on September 22, 2026, about a technical training center, and ROIV on September 23, 2026, about topline results for a proof-of-concept study. Financial reports were filed by UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Other updates include EPM on September 21, 2026, about upcoming investor conferences, and IPHA on September 17, 2026, with a 6-K filing. HTTP requests were successful for KGF, ASKUL, IPHA news, and SOBI with respective hashes. The fund will preserve monitors and has no orders, with a note to read originals and validate strong or new information, and to cash and reverify weak, absent, or error information, particularly for IPHA on September 17, 2026, and Sobi receipt conditional on Q1 2028.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 24, 2026, at 01:30:32 UTC. The fund is monitoring the following stocks: IONS, MIRM, GIS, EAT, and CAG. Recent SEC filings include IONS on September 23, MIRM on September 8, GIS on September 23, and EAT on September 17. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on September 23. GIS had a conference and review on September 8 at 19:40 UTC, which has already passed. The company also released its earnings on the morning of September 23, with a Q&A session at 13:00 UTC. The fund is using a baseline of July 1, FY27 EPS of 3.00-3.20, with organic growth of -1.5 to +0.5%, and savings of 750 million. The fund has a frozen paper window from September 16 to September 21, with a calendar out of sample of +0.567% and stress of -2.405%. EAT had an investor day on August 31, with a review on September 17 at 16:30 UTC. The company also announced its earnings call date for October 28, with a review scheduled for 16:30 UTC. The fund is monitoring the stocks' organic cash growth, with stronger growth leading to record and independent validation, and weaker or absent growth leading to cash reverification. The fund has a holdout of -19.2065% for EAT, with no automatic trade. The fund is verifying full pipelines and early news for the stocks.

The Catalyst fund is for research only and has a size of 0. On September 24, 2026, at 00:30:32 UTC, the fund manager reviewed the following information. The manager looked at SEC filings for CHWY from September 9, 2026, ASO from September 9, 2026, and LOVE from September 10, 2026. The manager also reviewed an 8-K filing from SFIX on September 23, 2026. Additionally, the manager checked RSS feeds from SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The manager also checked an FDA update for GRAL on September 23, 2026, which was a meeting of the Molecular and Clinical Genetics Panel, not an approval. The manager reviewed these items at the following times: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The manager made decisions based on strong cash positions, which were recorded and validated, and weak or early positions, which were cashed and reverified. No automatic orders were placed.

The Catalyst research fund has a size of 0 as of September 23, 2026, at 21:45:29 UTC. Recent news includes: TLX on September 20, 2026, about a partnership with ITM, AVO on September 8, 2026, about fiscal third-quarter financial results, ABM on September 22, 2026, about a technical training center, and ROIV on September 23, 2026, about topline results for a proof-of-concept study. There have been recent filings from UNFI on September 14, 2026, DRI on July 24, 2026, PPIH on September 9, 2026, MRK on August 7, 2026, and WLTH on September 14, 2026. Additionally, EPM announced participation in upcoming investor conferences on September 21, 2026, and IPHA filed a 6-K on September 17, 2026. HTTP requests to KGF, ASKUL, IPHAnews, and SOBI were successful with hashes 779e4855c061afea, e6f0d85c03a37ce6, ef3293fd5ff26cb3, and 7569409d160b2a08, respectively. Research notes include a conditional receipt for Sobi and Q1 2028, and preservation of monitors 165, 168, 167, 137, and 22. The sources and dates are recorded in the job script and journal, and no orders have been placed.

The Catalyst fund is currently researching IONS, MIRM, GIS, and EAT, with no active orders. As of September 23, 2026, at 21:15:32 UTC, the fund size is 0. The fund manager has reviewed SEC filings for IONS, MIRM, GIS, and EAT on September 23, 8, 23, and 17, respectively. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on September 23. GIS had a conference and review on September 8 at 19:40 UTC, which has already passed. On September 23, GIS released its morning earnings, with a Q&A session at 13:00 UTC, but the exact time of the first release is unknown. The fund manager will review GIS's stronger organic cash flow and guidance, but will not automatically enter a trade. The baseline for GIS's fiscal year 2027 is an EPS of 3.00-3.20, with organic growth of -1.5 to +0.5% and savings of 750 million. EAT had an investor day on August 31, with a review on September 17 at 16:30 UTC. EAT's earnings call date is October 28, but the hour and first release time are unknown. The fund manager will review EAT's stronger organic cash flow and guidance, but will not automatically enter a trade. The fund manager will verify the full pipelines and early news for all four companies, with a focus on IONS, MIRM, GIS, and EAT. As of September 23, 2026, at 21:15:35 UTC, the fund remains in research-only mode with no orders.

The fund is called Catalyst Research and it has a size of 0. It is compacting receipts and the origins are in the PRE91108 archive. This was done on 2026-09-23 at 20:45:22. The system has several panels of information, including SEC filings for HITI on 2026-09-23 and BFRI on 2026-09-14. There are also news previews, such as a report from Dave & Buster's on September 14, 2026, and a review of TSM on September 10. The system also mentions EGTX and its conferences on September 11 and 16. Additionally, there is information about BFRI's ITC and a lifted suspension on September 1. The system has 11 panels of information and a raw sha of 526e5107c7db79e75822161e4a8dbb95d97e3b1610c0da68351d04ab9e85ee62.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 23, 2026, at 20:30:19 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, LOVE on September 10, 2026, and SFIX on September 23, 2026. The manager also reviewed the following RSS feeds: SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. Additionally, the manager checked the FDA website for information on GRAL, which had a panel meeting on September 23, 2026. The manager noted that the SEC filings may lag behind news and scheduled reviews for the following dates and times: September 9 at 12:30 for new morning results, September 10 at 12:30 for LOVE, and September 24 at 12:30 for SFIX after the September 23 AMC. The manager also noted that the GRAL panel meeting on September 23 was not for approval. The manager made decisions based on strong cash positions, which were recorded and validated, and weak or early positions, which were cashed and reverified. No automatic orders were placed.

The fund is called Catalyst Research and it is for research only. The size of the fund is 0 and the time is 2026-09-23T17:45:20.121790+00:00. There are several news updates from various companies, including TLX on Sunday, September 20, 2026, with a link to their website, AVO on Tuesday, September 8, 2026, with a link to their news release, ABM on Tuesday, September 22, 2026, with a link to their news release, and ROIV on Wednesday, September 23, 2026, with a link to their news release. Additionally, there are several financial reports, including UNFI's 10-K report on September 14, 2026, DRI's 10-K report on July 24, 2026, PPIH's 10-Q report on September 9, 2026, MRK's 10-Q report on August 7, 2026, and WLTH's 10-Q report on September 14, 2026. There is also a news update from EPM on Monday, September 21, 2026, with a link to their news release, and a 6-K report from IPHA on September 17, 2026. The HTTP status codes for KGF, ASKUL, IPHAnews, and SOBI are all 200, with corresponding hashes. The research notes end with the instruction to preserve certain monitors and not to place any orders.

The Catalyst fund is currently in research mode only, with a size of 0, as of September 23, 2026, at 17:15:22 UTC. The fund is tracking the following stocks: IONS, MIRM, GIS, EAT, and CAG. The fund manager has reviewed the following SEC filings: IONS on September 23, MIRM on September 8, GIS on September 23, and EAT on September 17. A news scan found the headline 'Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease' on September 23. The GIS company had a conference on September 8 at 19:00 UTC, which has already passed. The fund manager will review the replay. On September 23, GIS released its morning earnings, with a Q&A session at 13:00 UTC. The fund manager will review the earnings release. If GIS has stronger organic cash flow and guidance, the fund manager will record and validate the results. If the results are weaker or absent, the fund manager will reverify the cash flow. The fund manager has set a baseline for GIS's fiscal year 2027, with an expected EPS of $3.00-3.20 and organic growth of -1.5% to +0.5%. The fund manager has also set a frozen paper window from September 16 to September 21, with a calendar out-of-sample performance of +0.567% and a stress performance of -2.405%. The fund manager will review EAT's investor day on September 17 and its earnings call on October 28. If EAT has stronger organic cash flow, the fund manager will record and validate the results. If the results are weaker or absent, the fund manager will reverify the cash flow. The fund manager has set a frozen holdout for EAT of -19.2065% and will not make any automatic trades. The fund manager will verify the full pipelines and early news for all stocks.

The Catalyst fund, which is for research only and has a size of 0, was updated on September 23, 2026, at 16:15:19 UTC. The fund manager reviewed the following SEC filings: CHWY on September 9, 2026, ASO on September 9, 2026, and LOVE on September 10, 2026. The manager also reviewed an 8-K filing from SFIX on July 28, 2026. Additionally, the manager checked RSS feeds from SAIL on September 22, 2026, KFY on September 9, 2026, and LOVE on September 15, 2026. The FDA calendar was also reviewed, which included a meeting on September 23, 2026, for GRAL, but this meeting was not for approval. The manager noted that the SEC filings may lag behind news. The manager will review the following: new morning results on September 9 at 12:30, LOVE on September 10 at 12:30, and SFIX on September 24 at 12:30 after the September 23 AMC. The manager will also review the GRAL panel on September 23. The manager uses a system where strong cash positions are recorded and validated, while weak or early positions are verified. No automatic orders were placed.